In the course of our studies on the chemistry of enaminoketones, 1) we synthesized some enamino-ketone Mannich base derivatives depicted by the general formula 1 (Chart 1), and found that most had strong opioid analgesic activity.
Among the derivatives synthesized, compound 1a or 1b showed higher analgesic acitivity than that of morphine, and both compounds had various pharmacological activities such as sedative, antitussive, or anticonvulsant activities. These results suggested that 1a or 1b can interact with a variety of receptors in the central nervous system. On the basis of those studies, we attempted the chemical modification of the prototype compound 1 as shown in Chart 2. Thus the alicyclic moiety (part A enclosed in the dotted lines in 1) was removed and the vinylogous amide moiety was divided into two amide moieties (parts B and C in structure 2), leading to the malonodiamide Mannich base 2. However, the synthesized compounds 2 were unstable. Therefore we planned to synthesize the Mannich base 3 in which the anilide moiety (part C in 2) was replaced with a benzamide group. This molecule 3 bears a marked structural resemblance to some dopamine antagonists. In this paper, we report the synthesis of novel benzamide derivatives (4 and 5 in Chart 3) with the general structure 3.
Results and Discussion
For the preparation of the target compounds 4 and 5 starting from b-piperidinoalanine 6, two rational synthetic pathways via amidation of this amino acid are possible. The efficient synthesis of starting material 6 and related compounds has already been reported. 3) To begin, we attempted the procedure via amidation of the carboxylic acid functionality. Thus treatment of 6 with methanolic hydrogen chloride gave the corresponding amino acid methyl ester 7 in excellent yield. The ester dihydrochloride 7 was reacted with methylamine and pyrrolidine to give corresponding amides 8 and 9 (87 and 72% yield, respectively), which were used in next step without further purification. Treatment of compound 8 with carboxylic acids in the presence of dicyclohexylcarbodiimide (DCC) gave the desired benzamide derivative 4. In a similar manner, the reaction of 9 with carboxylic acids afforded corresponding benzamide derivatives 5a-d. Since no reaction of 7 with piperidine occurred, 4) alternative amidation of the target compound 5e was investigated and we found that a method via mixed anhydride was efficient. Thus the reaction of 6 with benzoyl chloride under Schotten-Baumann reaction conditions gave N-[(1-carboxy)-2-(1-piperidinyl)-ethyl]benzamide 10 in good yield. The reactant of 10 with pivaloyl chloride, giving a corresponding mixed anhydride, was allowed to react with piperidine to provide the desired 5e in 50% yield. Using this procedure, compound 5a was also obtained from 10 and pyrrolidine in 63% yield (see Chart 3). This method via mixed anhydride was also applicable for the preparation of 4 and 5b-d and provides a new synthetic procedure for this class of compounds. The results are summarized in Table 1 .
5)
The molecules of 4 and 5 synthesized above have frameworks similar to those of tiapride 6) and metoclopramide 7) (Chart 4), which are clinically useful dopamine receptor antagonists. Molecular model examination of these compounds 8) suggested the possibility that compounds 4 and 5 may interact with the dopamine receptor. Further synthetic applications and pharmacological evaluations of the compounds synthesized are under investigation to find a new candidate with potent dopamine antagonist activity.
Experimental
Melting points were uncorrected. Infrared (IR) spectra were measured with a Shimadzu FTIR-8100 spectrometer.
1 H-(500 MHz) and 13 C-(125 MHz) NMR spectra were obtained with a JEOL JNM A-500. Chemical shifts were expressed as d ppm downfield from an internal tetramethylsilane (TMS) signal (0 ppm) or sodium 3-(trimethylsilyl)propionic 2, Methyl a a -Amino-1-piperidinepropanoate Dihydrochloride (7) Methanolic HCl (10%) was added to a solution of 6 in anhydrous methanol and the mixture was kept at room temperature for 24 h, then evaporated to dryness in vacuo. After a few such treatments with methanolic HCl, the residue finally crystallized completely. The yield was quantitative. Recrystallization from methanol gave an analytical sample of 7. This compound was colorless prisms and quite hygroscopic, mp 178°C (dec. a a-Amino-N-methyl-1-piperidinepropionamide (8) Methyl a-amino-1-piperidinepropanoate dihydrochloride 7 (2 g, 7.7 mmol) was added to a 40% solution of methylamine in methanol (6 ml) and the reaction mixture was allowed to stand at room temperature for 3 h, then the solvent was evaporated to dryness. After addition of Et 2 O to the residue, the separated precipitate was isolated by filtration. The filtrate was concentrated to dryness to give 8 (1.06 g, 74%). The precipitate was made basic with small amount of aqueous NaOH (ca. 2%), extracted with AcOEt, and the extract was concentrated to dryness to give 8 (0.18 g, 13% 
2-Amino-3-(1-piperidinyl)-1-(1-pyrrolidinyl)-1-propanone (9)
Methyl a-amino-1-piperidinepropanoate dihydrochloride 7 (2 g, 7.7 mmol) was added to pyrrolidine (5.5 ml) and stirred for 4 h. Et 2 O was added to the reaction mixture and the precipitate was filtered off. The ethereal solution was concentrated, and the excess pyrrolidine was removed under reduced pressure to give 9 (1.31 g, 75% a a-(Benzoylamino)-1-piperidinepropanoic Acid (10) Using a threeneck round-bottomed flask, benzoyl chloride (8.03 g, 57 mmol) was added dropwise to a vigorously stirred solution of 6 (7 g, 28.6 mmol) in 1 N NaOH (86 ml) and 2 N NaOH (43 ml) was added at the same time. In this experiment, it is advantageous to terminate the addition of both reagents together. The reaction mixture was stirred for 2 h at room temperature and then acidified with 20% HCl. The resulting mixture was washed with diethyl ether (Et 2 O) and the resulting aqueous layer was evaporated to give residual oil. After the addition of ethanol to this residue, the precipitated insoluble solid was removed by filtration. The mother liquor was concentrated to dryness. The residue was passed through a column packed with ion-exchange resin (AG 11A8 ® , Bio-Rad Laboratories) to give crude product, which was recrystallized from H 2 O to afford 10 (5.3 g, 67%), mp 139-141°C (dec. N-[2-(1-Piperidinyl)-1-(1-piperidinylcarbonyl) ethyl]benzamide (5e) (Method via Mixed Anhydride) To a solution of compound 10 (1 g, 3.6 mmol) and N-methylmorpholine (0.56 g, 5.5 mmol) in anhydrous dimethylformamide (DMF) (50 ml), pivaloyl chloride (0.67 g, 5.5 mmol)was added at Ϫ15°C with stirring. After 5 min, piperidine (0.47 g, 5.5 mmol) was added and the reaction mixture was allowed to stand at 0°C for 30 min and then overnight at room temperature with stirring. The reaction mixture was concentrated in vacuo, the residue was extracted with 1 N HCl, and the aqueous solution was washed with Et 2 O and basified with K 2 CO 3 . The resulting precipitate was collected by filtration, washed with water, and dried to give 5e (0.62 g, 50%), which was recrystallized from CH 3 CN to afford colorless needles. IR (KBr): 3300, 1653, 1619 cm 
